A detailed history of Pro Share Advisors LLC transactions in Enochian Biosciences Inc stock. As of the latest transaction made, Pro Share Advisors LLC holds 24,571 shares of ENOB stock, worth $113,026. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,571
Previous 32,570 24.56%
Holding current value
$113,026
Previous $149,000 24.16%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 08, 2025

SELL
N/A
-7,999 Reduced 24.56%
24,571 $113,000
Q4 2024

Feb 13, 2025

BUY
N/A
32,570 New
32,570 $149,000

Others Institutions Holding ENOB

About Enochian Biosciences Inc


  • Ticker ENOB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,950,000
  • Market Cap $244M
  • Description
  • Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for au...
More about ENOB
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.